Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00870675 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging (MRI) of Ventriculomegaly: Morphology and Outcome
A clinical trial of Ventriculomegaly, sponsored by National Institute for Biomedical Imaging and Bioengineering (NIBIB).
- Completed
- Registry status
- 434
- Enrollment target
- 1
- Study location
NCT00870675: Completed study of Ventriculomegaly, sponsored by National Institute for Biomedical Imaging and Bioengineering (NIBIB).
NCT00870675 is a study of Ventriculomegaly that has completed, run by National Institute for Biomedical Imaging and Bioengineering (NIBIB). The registered enrollment target is 434 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00870675, a study of Ventriculomegaly, has completed, sponsored by National Institute for Biomedical Imaging and Bioengineering (NIBIB).
- COMPLETED
- Registry status
- 434 participants
- Enrollment target
- 1
- Study location
Study Summary
This study compares the accuracy of fast magnetic resonance imaging (MRI) using the half Fourier single shot rapid acceleration with relaxation enhancement technique to ultrasound in the diagnosis of fetal abnormalities. The investigators' specific aim is to perform MRI examinations with ultrafast MRI on fetuses with sonographic morphologic abnormalities. The investigators' hypotheses are that 1) MRI will demonstrate fetal morphologic abnormalities; and 2) MRI will add additional information to the sonographic diagnosis which may directly affect maternal and/or neonatal care.
Conditions Studied
Study Locations (1)
Massachusetts
- Childrens Hospital Boston - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 434 participants |
| Start Date | 1996-01 |
| Est. Completion | 2011-06 |
What the finished NCT00870675 record still lists
NCT00870675 is an observational study that tracks outcomes without assigning an intervention. The registered 434 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Ventriculomegaly appearing as the primary indexed condition, and to 0 interventions.
NCT00870675 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00870675 about?
NCT00870675 is a clinical study titled "Magnetic Resonance Imaging (MRI) of Ventriculomegaly: Morphology and Outcome". This study compares the accuracy of fast magnetic resonance imaging (MRI) using the half Fourier single shot rapid acceleration with relaxation enhancement technique to ultrasound in the diagnosis of fetal abnormalities. The investigators' specific aim is to perform MRI examinations with ultrafast M...
What is the current status of trial NCT00870675?
This trial is currently completed. The enrollment target is 434 participants. The study started on 1996-01. Estimated completion is 2011-06.
What conditions does trial NCT00870675 study?
This clinical trial studies the following conditions: Ventriculomegaly.
Who is sponsoring clinical trial NCT00870675?
This trial is sponsored by National Institute for Biomedical Imaging and Bioengineering (NIBIB), which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00870675 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04743245 · 434 participants · NA
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
- NCT06471920 · 434 participants · NA
Improving Health for Patients With Chronic LBP in Rural Communities Through Telerehabilitation
- NCT07094113 · 434 participants · Phase 1
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- NCT05563220 · 435 participants · Phase 1
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia